Premier Turnkey CRO Facility for Sale in Ohio: A Unique Opportunity for Bidders

Unique Opportunity: Premier CRO Facility for Sale

The contract research organization (CRO) market is poised for a significant shift, as Hilco Global announces the upcoming sale of a top-notch CRO facility that was previously utilized by AmplifyBio. Set against the backdrop of bankruptcy proceedings, this facility in West Jefferson, Ohio, presents a once-in-a-lifetime chance for bidders until the deadline of August 15, 2025.

Details of the Facility

Spanning approximately 205,000 square feet, this facility boasts around 65,000 square feet dedicated to specialized laboratory space, along with a 64-room vivarium. The unique design promotes a one-way traffic flow intended to bolster research efficiency, ensuring an ideal environment for high-complexity, regulated studies. The facility is equipped with an on-site surgical suite, facilitating a wide array of clinical research applications, particularly for pharmaceuticals and medical devices.

Infrastructure and Offerings

Engineered specifically for advanced research, this CRO facility includes state-of-the-art laboratories tailored to deliver comprehensive toxicology assessments, safety pharmacology, and bioanalytical characterization. This strategic setup is crucial for the innovation of modern therapeutics, making it highly appealing to potential buyers in the biotechnology sector.

AmplifyBio itself was established in 2021 and quickly emerged as a leader in advanced therapy development, showcasing innovative technologies ranging from gene editing to T cell-based therapies. With substantial backing, exceeding $200 million, the company offered integrated preclinical research and development, safety assessments, and Good Manufacturing Practice (GMP) services to a diverse clientele in the biopharmaceutical arena.

A Rare Chance for Buyers

This sale stands as a remarkable prospect for buyers aiming to acquire a turnkey CRO operation. "The facility’s Class-A laboratory and office spaces are designed to accommodate various advanced research applications," remarked Joel Schneider, Senior Vice President at Hilco Real Estate. The sale includes highly sophisticated equipment ideal for a broad spectrum of research projects, elevating the appeal for contract research organizations or any related ventures looking for a well-maintained infrastructure.

In addition to the physical assets, the amplification of this offer extends to the robust patent portfolio held by AmplifyBio, featuring 119 issued and pending patents primarily focusing on immunotherapy and cell engineering. According to David Peress, Executive Vice President with Hilco Streambank, this collection represents a forward-thinking opportunity for buyers interested in clinically validated innovations that hold promise in oncology and personalized medicine.

Next Steps for Interested Bidders

Bidders wishing to take part in this exceptional sale must submit their offers by noon (EST) on August 15, 2025. Submission entails adherence to the existing stalking horse Asset Purchase Agreement, accessible for review on Hilco Real Estate Sales’ website.

Potential bidders are encouraged to familiarize themselves with the court-approved bidding procedures, which outline the requirements needed to successfully engage in this sale process. For further inquiries or the possibility of an on-site inspection, interested parties should reach out to Chet Evans at (847) 418-2702 or via email at [email protected].

For additional information and access to due diligence and other vital details, bidders can visit Hilco Real Estate Sales’ Virtual Data Room. This acquisition could represent a critical step for companies within the CRO space, further enhancing the landscape of pharmaceutical and medical device research.

About Hilco Global

Hilco Global, headquartered in Northbrook, Illinois, is recognized as the premier authority in maximizing the value of business assets. Offering valuation, monetization, and advisory solutions across an international marketplace, Hilco Global operates over twenty specialized business units, focusing on a broad spectrum of services, including asset appraisal, retail and industrial inventory management, and real estate investment. Their extensive footprint spans various US cities, including Boston, Detroit, Chicago, New York, and Philadelphia, as well as international locations, ensuring a robust presence in the global market.